The authors show that knocking out SMAD4, human NK cells resist TGFβ and activin A suppression and demonstrate that SMAD4 knockout enhances the antitumor function of several NK cell products in clinical development.
- Anna Rea
- Sara Santana-Hernández
- Aura Muntasell